CN103239702A - Medicament for treating dysmenorrhea - Google Patents

Medicament for treating dysmenorrhea Download PDF

Info

Publication number
CN103239702A
CN103239702A CN2013101972773A CN201310197277A CN103239702A CN 103239702 A CN103239702 A CN 103239702A CN 2013101972773 A CN2013101972773 A CN 2013101972773A CN 201310197277 A CN201310197277 A CN 201310197277A CN 103239702 A CN103239702 A CN 103239702A
Authority
CN
China
Prior art keywords
radix
fructus
dysmenorrhea
rhizoma
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2013101972773A
Other languages
Chinese (zh)
Inventor
温美珍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2013101972773A priority Critical patent/CN103239702A/en
Publication of CN103239702A publication Critical patent/CN103239702A/en
Pending legal-status Critical Current

Links

Abstract

The invention relates to a medicament for treating dysmenorrhea. The medicament is prepared from traditional Chinese medicines as bulk pharmaceuticals. A tablet product of the medicament is prepared by using the steps of uniformly mixing rhizoma cyperi, three-nerved spicebush root, szechwan Chinaberry fruit, rhizoma corydalis, fennel, folium artemisiae argyi, fructus evodiae, baked ginger, pseudo-ginseng, ligusticum wallichii, myrrh, pollen typhae, trogopterus dung, herba lycopi, morinda officinalis, fructus psoraleae, astragalus mongholicus, Chinese angelica, elecampane and Chinese thorowax root, crushing the mixture into 100-200 meshes of powder and tableting the powder according to a conventional method. The medicament is used for treating by taking the purposes of prompting qi circulation to relive pain, warming channels, invigorating blood circulation, nourishing liver and kidney, benefiting qi and nourishing blood as principles and has a good treatment on dysmenorrhea and no side effect.

Description

A kind of medicine for the treatment of dysmenorrhea
Technical field
The present invention relates to a kind of medicine for the treatment of dysmenorrhea, especially relating to a kind of is the medicine of the treatment dysmenorrhea of crude drug preparation with Chinese medicine.
Background technology
Dysmenorrhea is also referred to as pain in menstrual period, is clinical common disease, is mainly in the youth.Pain was common and betided most of menstrual cycle periodic menstrual period, dysmenorrhea often be angor and with the lower back portion pain, feel sick, vomiting, headache or suffer from diarrhoea.Dysmenorrhea is divided into primary dysmenorrhea and secondary dysmenorrhea two classes, and primary dysmenorrhea refers to that the genitals does not have the dysmenorrhea of organic disease, accounts for more than 90% of dysmenorrhea; Secondary dysmenorrhea refers to the dysmenorrhea that the pelvic cavity organic disease causes, endometriosis, adenomyosis are the common causes of secondary dysmenorrhea.Many women can have the situation of slight discomfort in menstrual period, but this can not think simply that dysmenorrhea, dysmenorrhea refer to that the pain in menstrual period has influenced normal activity, and needs Drug therapy, dysmenorrhea can have a strong impact on women's operate as normal life, severe patient even may cause infertility.
Summary of the invention
The purpose of this invention is to provide a kind of is the medicine of the treatment dysmenorrhea of crude drug preparation with Chinese medicine, and this medicine is with promoting the circulation of QI to relieve pain, and warming the meridian and activating blood circulation, nourishing the liver and kidney, benefiting qi and nourishing blood are the principle treatment, and be effective to TREATMENT OF DYSMENORRHOEA, has no side effect.
Medicine of the present invention is that crude drug prepares by following parts by weight of traditional Chinese medicines:
Rhizoma Cyperi 8~12 Radixs Linderae 8~12 Fructus Toosendans 8~12 Rhizoma Corydalis 8~12
Fructus Foeniculi 6~10 Folium Artemisiae Argyis 8~12 Fructus Evodiaes 6~10 Rhizoma Zingiberis Preparatums 6~10
Radix Notoginseng 8~12 Rhizoma Chuanxiongs 8~12 Myrrhas 4~8 Pollen Typhaes 6~10
Oletum Trogopterori 6~10 Herba Lycopi 6~10 Radix Morindae Officinaliss 8~12 Fructus Psoraleaes 8~12
The Radix Astragali 8~12 Radix Angelicae Sinensis 8~12 Radix Aucklandiae 6~10 Radix Bupleuri 6~10.
Preferably, medicine of the present invention is that crude drug prepares by following parts by weight of traditional Chinese medicines:
Rhizoma Cyperi 10 Radixs Linderae 10 Fructus Toosendans 10 Rhizoma Corydalis 10
Fructus Foeniculi 8 Folium Artemisiae Argyis 10 Fructus Evodiaes 8 Rhizoma Zingiberis Preparatums 8
Radix Notoginseng 10 Rhizoma Chuanxiongs 10 Myrrhas 6 Pollen Typhaes 8
Oletum Trogopterori 8 Herba Lycopi 8 Radix Morindae Officinaliss 10 Fructus Psoraleaes 10
The Radix Astragali 10 Radix Angelicae Sinensis 10 Radix Aucklandiae 8 Radix Bupleuri 8.
The medicine of above-mentioned each component can be made said peroral dosage form on any pharmaceuticss such as powder, capsule, pill, and the preferred dosage form of the present invention is tablet.
The concrete preparation method of medicinal tablet of the present invention is: said medicine by described parts by weight mix homogeneously, is ground into 100~120 purpose medicated powder, and tabletting makes the tablet product according to a conventional method.
The traditional Chinese medical science thinks dysmenorrhea mainly owing to qi depression to blood stasis, obstructed, the deficient qi and blood of stagnating, dash and appoint deficient causing.Dysmenorrhea patient's feelings will is unsuccessful, the irritability depression, and duration dash to be appointed, and uterus stagnation of QI blood is contained, mechanism of qi retardance and cause qi depression to blood stasis and cause dysmenorrhea; Cold having the property of coagulation easily blocks yang-energy, brave the rain menstrual period, paddle, occupy for a long time wetland, cold-damp is hindered in the part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels, surfeit is cold and cool, cold originating from the interior or innate deficiency of YANG in the body, yin-cold excess, the cold-evil is objective appoints in dashing, meet again through preceding menstrual period dash to appoint, the uterus QI and blood stops up and contains, the cold-evil fights mutually with QI and blood and causes sluggish obstructed initiation dysmenorrhea; The kidney being the origin of congenital constitution, spleen kidney deficiency or intemperate sexual intercourse, voluminous exhaustion due to sexual indulgence, liver-blood deficiency, through after essence and blood benefit empty, dash that to appoint a uterus to lose in moistening foster, deficient qi and blood, dash and appoint deficient and cause dysmenorrhea; In a word, dysmenorrhea with qi depression to blood stasis, cold coagulation uterus, deficient qi and blood, dash appoint deficient be main diseases because of.The Therapeutic Principle should be promoting the circulation of QI to relieve pain, warming the meridian and activating blood circulation, nourishing the liver and kidney, benefiting qi and nourishing blood.Rhizoma Cyperi, the Radix Linderae, Fructus Toosendan, Rhizoma Corydalis, the Radix Aucklandiae, Radix Bupleuri play the circulation of qi promoting effect of having a respite jointly in the prescription of the present invention, and a uterus dash to be appointed in the dysmenorrhoea disease position, and fortuneization is in QI and blood, and the capable then blood of gas is capable, and gas transfers then pain certainly only along blood; Fructus Foeniculi, Folium Artemisiae Argyi, Fructus Evodiae, Rhizoma Zingiberis Preparatum be the product of warming YANG all, and yang-energy general rule gas is logical, dash and appoint the uterus QI-blood circulation freely then not bitterly; Blood stasis can cause pain, and it is the main cause of dysmenorrhea that blood stasis is stagnated, the present invention with Radix Notoginseng, Rhizoma Chuanxiong, Myrrha, Pollen Typhae, Oletum Trogopterori, the common blood circulation promoting and blood stasis dispelling of Herba Lycopi blood is transferred and pain only." element is asked .Ancient times, innocence was discussed " say " menarche, conception vessel is logical, the favourable opposition full and forceful pulse, menses is with under the thing ", wantonly two arteries and veins are dashed in normally depending on of menstruation.Noted liver and kidney tonifying among the present invention, benefiting vital QI and blood, Radix Morindae Officinalis in the side, Fructus Psoraleae, the Radix Astragali, Radix Angelicae Sinensis and the liver and the kidney tonifying.In a word, our various medicines are played altogether, promoting the circulation of QI to relieve pain, and warming the meridian and activating blood circulation, nourishing the liver and kidney, benefiting qi and nourishing blood and play analgesic effect altogether can play the purpose of taking stopgap measures and effecting a permanent cure to TREATMENT OF DYSMENORRHOEA.
For further investigating the clinical efficacy of Drug therapy dysmenorrhea of the present invention, select 64 routine dysmenorrhea patients to carry out clinical observation on the therapeutic effect.
64 routine patients are all according to the diagnosis basis in " disease of tcm diagnosis criterion of therapeutical effect ":
1, menstrual period or before and after row lower abdomen pain, pain and waist sacrum are very then fainted.Be periodical attack;
2, good sending out in young maiden;
3, suffer from abdominal pain due to the eliminating pelvic cavity organic disease;
Be diagnosed as dysmenorrhea.
Therapeutic Method
Adopt tablet medicine of the present invention, 3 times on the one, each 10, every 0.5g.
Criterion of therapeutical effect
Criterion of therapeutical effect with reference to " disease of tcm diagnosis criterion of therapeutical effect ".Cure: pain disappears, and recurrence is seen at continuous 3 menstrual cycle ends; Take a turn for the better: pain relief or pain disappear, but can not keep more than 3 months; Do not heal: pain is not seen improvement.
All case treatment back efficacy result sees Table 1.
Table 1 is case treatment back efficacy result all.
The example number Cure n(%) Improvement n(%) N(% more) Total effective rate n(%)
64 40(62.5) 21(32.8) 3(4.7) 61(95.3)
 
Concrete case
Case one
Zhang, woman, 17 years old, suffered from dysmenorrhea 4 years, body constitution is thin and weak usually, and 13 years are through menophania, menstruation irregularis, 4-7/20-50 days, the 2-3 day pain of menstruation very accompanied pale complexion, extreme cold of the limbs, pain alleviated while getting warmth, treatments such as oral YUANHU ZHITONG PIAN, ibuprofen, Aifu Nuangong Wan are once imitated not good enough, and learning pressure increases the weight of greatly.Use tablet medicine of the present invention, every day three times, each 10, the treatment back takes a turn for the better.
Case two
The king so-and-so, 23 years old, 14 years were through rising, dysmenorrhea always after the menophania was married in 22 years old, 1 son is arranged after marriage, plain body still can, menstruation 4-5/22-25 days, amount is few, color is dim, dysmenorrhea continues whole menstrual period, and preceding 2 days pains very need be taken the somedon pain relieving at every turn, once takes western medicines in treatment and imitates not good enough.Use tablet medicine treatment of the present invention back to cure.
The specific embodiment
Embodiment 1
Get Rhizoma Cyperi 8g, the Radix Linderae 8 g, Fructus Toosendan 8 g, Rhizoma Corydalis 8 g, Fructus Foeniculi 6 g, Folium Artemisiae Argyi 8 g, Fructus Evodiae 6 g, Rhizoma Zingiberis Preparatum 6 g, Radix Notoginseng 8 g, Rhizoma Chuanxiong 8 g, Myrrha 4 g, Pollen Typhae 6 g, Oletum Trogopterori 6 g, Herba Lycopi 6 g, Radix Morindae Officinalis 8 g, Fructus Psoraleae 8 g, the Radix Astragali 8 g, Radix Angelicae Sinensis 8 g, the Radix Aucklandiae 6 g, Radix Bupleuri 6 g mix homogeneously, be ground into 100~120 purpose medicated powder, tabletting makes the tablet product according to a conventional method.
Embodiment 2
Get Rhizoma Cyperi 12g, the Radix Linderae 12 g, Fructus Toosendan 12 g, Rhizoma Corydalis 12 g, Fructus Foeniculi 10 g, Folium Artemisiae Argyi 12 g, Fructus Evodiae 10 g, Rhizoma Zingiberis Preparatum 10 g, Radix Notoginseng 12 g, Rhizoma Chuanxiong 12 g, Myrrha 8 g, Pollen Typhae 10 g, Oletum Trogopterori 10 g, Herba Lycopi 10 g, Radix Morindae Officinalis 12 g, Fructus Psoraleae 12 g, the Radix Astragali 12 g, Radix Angelicae Sinensis 12 g, the Radix Aucklandiae 10 g, Radix Bupleuri 10 g mix homogeneously, be ground into 100~120 purpose medicated powder, tabletting makes the tablet product according to a conventional method.
Embodiment 3
Get Rhizoma Cyperi 10 g, the Radix Linderae 10 g, Fructus Toosendan 10 g, Rhizoma Corydalis 10 g, Fructus Foeniculi 8 g, Folium Artemisiae Argyi 10 g, Fructus Evodiae 8 g, Rhizoma Zingiberis Preparatum 8 g, Radix Notoginseng 10 g, Rhizoma Chuanxiong 10 g, Myrrha 6 g, Pollen Typhae 8 g, Oletum Trogopterori 8 g, Herba Lycopi 8 g, Radix Morindae Officinalis 10 g, Fructus Psoraleae 10 g, the Radix Astragali 10 g, Radix Angelicae Sinensis 10 g, the Radix Aucklandiae 8 g, Radix Bupleuri 8 g mix homogeneously, be ground into 100~120 purpose medicated powder, tabletting makes the tablet product according to a conventional method.

Claims (3)

1. medicine for the treatment of dysmenorrhea is that crude drug prepares by the Chinese medicine of following portions by weight:
Rhizoma Cyperi 8~12 Radixs Linderae 8~12 Fructus Toosendans 8~12 Rhizoma Corydalis 8~12
Fructus Foeniculi 6~10 Folium Artemisiae Argyis 8~12 Fructus Evodiaes 6~10 Rhizoma Zingiberis Preparatums 6~10
Radix Notoginseng 8~12 Rhizoma Chuanxiongs 8~12 Myrrhas 4~8 Pollen Typhaes 6~10
Oletum Trogopterori 6~10 Herba Lycopi 6~10 Radix Morindae Officinaliss 8~12 Fructus Psoraleaes 8~12
The Radix Astragali 8~12 Radix Angelicae Sinensis 8~12 Radix Aucklandiae 6~10 Radix Bupleuri 6~10.
2. the medicine for the treatment of dysmenorrhea according to claim 1 is that crude drug prepares by the Chinese medicine of following portions by weight:
Rhizoma Cyperi 10 Radixs Linderae 10 Fructus Toosendans 10 Rhizoma Corydalis 10
Fructus Foeniculi 8 Folium Artemisiae Argyis 10 Fructus Evodiaes 8 Rhizoma Zingiberis Preparatums 8
Radix Notoginseng 10 Rhizoma Chuanxiongs 10 Myrrhas 6 Pollen Typhaes 8
Oletum Trogopterori 8 Herba Lycopi 8 Radix Morindae Officinaliss 10 Fructus Psoraleaes 10
The Radix Astragali 10 Radix Angelicae Sinensis 10 Radix Aucklandiae 8 Radix Bupleuri 8.
3. the medicine for the treatment of dysmenorrhea according to claim 1 is characterized in that described medicine is made tablet.
CN2013101972773A 2013-05-24 2013-05-24 Medicament for treating dysmenorrhea Pending CN103239702A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2013101972773A CN103239702A (en) 2013-05-24 2013-05-24 Medicament for treating dysmenorrhea

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2013101972773A CN103239702A (en) 2013-05-24 2013-05-24 Medicament for treating dysmenorrhea

Publications (1)

Publication Number Publication Date
CN103239702A true CN103239702A (en) 2013-08-14

Family

ID=48919805

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2013101972773A Pending CN103239702A (en) 2013-05-24 2013-05-24 Medicament for treating dysmenorrhea

Country Status (1)

Country Link
CN (1) CN103239702A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103520698A (en) * 2013-10-30 2014-01-22 倪惠君 Drug used for treating dysmenorrhea
CN104324149A (en) * 2014-11-09 2015-02-04 新疆阿勒泰地区哈萨克医医院 Medicament for dysmenorrhea and preparation method thereof
CN104436064A (en) * 2014-12-17 2015-03-25 周连才 Pharmaceutical composition for treating dysmenorrhea
CN105944047A (en) * 2016-03-22 2016-09-21 季晓斌 Traditional Chinese medicine composition for treating dysmenorrhea
CN106109802A (en) * 2016-09-05 2016-11-16 上海市针灸经络研究所 A kind of Chinese medicine composition treating primary dysmenorrhea and its production and use
CN106890308A (en) * 2017-03-23 2017-06-27 东南大学 It is a kind of to treat Chinese medicine composition of dysmenorrhoea and its preparation method and application
CN107198734A (en) * 2017-05-23 2017-09-26 张宇 The traditional Chinese herbal decoction of menstruction regulating and pain relieving
CN108653680A (en) * 2018-07-28 2018-10-16 遵义医学院珠海校区 A kind of navel paster for treating menorrhalgia of cold-stagnation and blood-stasis type

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102205103A (en) * 2011-05-13 2011-10-05 葛晓云 Pure Chinese medicinal plaster for treating dysmenorrhea
CN102688361A (en) * 2011-03-21 2012-09-26 天士力制药集团股份有限公司 Traditional Chinese medicinal composition for treating dysmenorrhoea and preparation thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102688361A (en) * 2011-03-21 2012-09-26 天士力制药集团股份有限公司 Traditional Chinese medicinal composition for treating dysmenorrhoea and preparation thereof
CN102205103A (en) * 2011-05-13 2011-10-05 葛晓云 Pure Chinese medicinal plaster for treating dysmenorrhea

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
李小丽: "中医药治疗寒凝血瘀型痛经概况", <<湖南中医杂志>> *
韩江余: "国内近10年痛经治疗组方用药规律数据分析", <<山东中医杂志>> *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103520698A (en) * 2013-10-30 2014-01-22 倪惠君 Drug used for treating dysmenorrhea
CN104324149A (en) * 2014-11-09 2015-02-04 新疆阿勒泰地区哈萨克医医院 Medicament for dysmenorrhea and preparation method thereof
CN104324149B (en) * 2014-11-09 2018-12-07 新疆阿勒泰地区哈萨克医医院 Dysmenorrhea drug and preparation method thereof
CN104436064A (en) * 2014-12-17 2015-03-25 周连才 Pharmaceutical composition for treating dysmenorrhea
CN105944047A (en) * 2016-03-22 2016-09-21 季晓斌 Traditional Chinese medicine composition for treating dysmenorrhea
CN106109802A (en) * 2016-09-05 2016-11-16 上海市针灸经络研究所 A kind of Chinese medicine composition treating primary dysmenorrhea and its production and use
CN106109802B (en) * 2016-09-05 2019-12-06 上海市针灸经络研究所 Traditional Chinese medicine composition for treating primary dysmenorrhea and preparation method and application thereof
CN106890308A (en) * 2017-03-23 2017-06-27 东南大学 It is a kind of to treat Chinese medicine composition of dysmenorrhoea and its preparation method and application
CN106890308B (en) * 2017-03-23 2018-05-15 东南大学 A kind of Chinese medicine composition for treating dysmenorrhoea and its preparation method and application
CN107198734A (en) * 2017-05-23 2017-09-26 张宇 The traditional Chinese herbal decoction of menstruction regulating and pain relieving
CN108653680A (en) * 2018-07-28 2018-10-16 遵义医学院珠海校区 A kind of navel paster for treating menorrhalgia of cold-stagnation and blood-stasis type

Similar Documents

Publication Publication Date Title
CN102151325B (en) Traditional Chinese medicine for treating breast diseases
CN103239702A (en) Medicament for treating dysmenorrhea
WO2004002503A1 (en) Compositions and methods for treating gynaecological disorders
CN103933353A (en) Medicament for treating rheumatism and gout
CN1327864C (en) Chinese traditional medicine for treating constipation
CN102178922A (en) Traditional Chinese medicine composition for treating dysmenorrhea and preparation method thereof
CN103495055A (en) Traditional Chinese medicine decoction for treating female endocrine disorders and preparation method thereof
CN103191375A (en) Traditional Chinese medicine composition for treating chronic pelvic inflammatory diseases
CN105031331B (en) A kind of navel patch and preparation method thereof for treating dysmenorrhea
CN103211886A (en) Medicament for treating rheumatic arthritis
CN104043053A (en) Traditional Chinese medicine for treating dysmenorrhea
CN103830672A (en) Traditional Chinese medicine for treating scapulohumeral periarthritis
CN104162088A (en) Traditional Chinese medicine composition for relieving rigidity of muscles, activating collaterals and eliminating dampness and preparation method thereof
CN103585609A (en) Traditional Chinese medicine composition for treating dysmenorrhea and preparation method thereof
CN104147209B (en) A kind of medicine and application thereof for the treatment of chronic pelvic inflammatory disease
CN102091296A (en) Medicament for treating breast hyperplasia
CN101129718B (en) Traditional Chinese medicine preparation for treating leuoderma
CN104042739A (en) Traditional Chinese medicine for treating prospermia
CN104258275A (en) Traditional Chinese medicinal composition for treating benign ovarian tumor with syndrome of internal blood stasis
CN104027430A (en) Traditional Chinese medicine composition for treating blood stasis type uterine myoma
CN106177774A (en) A kind of medicine treating pelvic inflammatory disease
CN103479960A (en) Chronic Hepatitis B disease treatment Chinese herbal
CN104173995A (en) Traditional Chinese medicine preparation for treating dysmenorrhea
CN102764325B (en) Chinese medicinal composition for dispelling rheumatism and relieving pain
CN102028768A (en) Traditional Chinese medicament for treating lumbar canal stenosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20130814